A case of thyrotoxicosis-induced anemia in a patient with painless thyroiditis.

IF 1.9 Q3 ENDOCRINOLOGY & METABOLISM
Ichiro Komiya, Takeaki Tomoyose, Noriharu Yagi, Gen Ouchi, Tamio Wakugami
{"title":"A case of thyrotoxicosis-induced anemia in a patient with painless thyroiditis.","authors":"Ichiro Komiya,&nbsp;Takeaki Tomoyose,&nbsp;Noriharu Yagi,&nbsp;Gen Ouchi,&nbsp;Tamio Wakugami","doi":"10.1186/s13044-021-00100-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>There have been several reports of secondary anemia associated with Graves' disease. There are no reports of secondary anemia resulting from thyrotoxicosis due to painless thyroiditis (silent thyroiditis). We report the case of a patient with pancreatic diabetes who developed anemia caused by thyrotoxicosis due to painless thyroiditis.</p><p><strong>Case presentation: </strong>The patient was a 37-year-old man who visited the hospital complaining of fatigue, palpitations, and dyspnea. His hemoglobin was 110 g/l (reference range, 135-176), and mean corpuscular volume was 81.5 fl (81.7-101.6). His free thyroxine (FT4) was high, at 100.4 pmol/l (11.6-21.9); the free triiodothyronine (FT3) was high, at 27.49 pmol/l (3.53-6.14); TSH was low, at < 0.01 mIU/l (0.50-5.00); and TSH receptor antibody was negative. Soluble IL-2 receptor (sIL-2R) was high, at 1340 U/ml (122-496); C-reactive protein (CRP) was high, at 6900 μg/l (< 3000); and reticulocytes was high, at 108 10<sup>9</sup> /l (30-100). Serum iron (Fe) was 9.5 (9.1-35.5), ferritin was 389 μg/l (13-401), haptoglobin was 0.66 g/l (0.19-1.70. Propranolol was prescribed and followed up. Anemia completely disappeared by 12 weeks after disease onset. Thyroid hormones and sIL-2R had normalized by 16 weeks after onset. He developed mild hypothyroidism and was treated with L-thyroxine at 24 weeks.</p><p><strong>Conclusions: </strong>This is the first case report of transient secondary anemia associated with thyrotoxicosis due to painless thyroiditis. The change in sIL-2R was also observed during the clinical course of thyrotoxicosis and anemia, suggesting the immune processes in thyroid gland and bone marrow.</p>","PeriodicalId":39048,"journal":{"name":"Thyroid Research","volume":"14 1","pages":"9"},"PeriodicalIF":1.9000,"publicationDate":"2021-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13044-021-00100-6","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thyroid Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s13044-021-00100-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 1

Abstract

Background: There have been several reports of secondary anemia associated with Graves' disease. There are no reports of secondary anemia resulting from thyrotoxicosis due to painless thyroiditis (silent thyroiditis). We report the case of a patient with pancreatic diabetes who developed anemia caused by thyrotoxicosis due to painless thyroiditis.

Case presentation: The patient was a 37-year-old man who visited the hospital complaining of fatigue, palpitations, and dyspnea. His hemoglobin was 110 g/l (reference range, 135-176), and mean corpuscular volume was 81.5 fl (81.7-101.6). His free thyroxine (FT4) was high, at 100.4 pmol/l (11.6-21.9); the free triiodothyronine (FT3) was high, at 27.49 pmol/l (3.53-6.14); TSH was low, at < 0.01 mIU/l (0.50-5.00); and TSH receptor antibody was negative. Soluble IL-2 receptor (sIL-2R) was high, at 1340 U/ml (122-496); C-reactive protein (CRP) was high, at 6900 μg/l (< 3000); and reticulocytes was high, at 108 109 /l (30-100). Serum iron (Fe) was 9.5 (9.1-35.5), ferritin was 389 μg/l (13-401), haptoglobin was 0.66 g/l (0.19-1.70. Propranolol was prescribed and followed up. Anemia completely disappeared by 12 weeks after disease onset. Thyroid hormones and sIL-2R had normalized by 16 weeks after onset. He developed mild hypothyroidism and was treated with L-thyroxine at 24 weeks.

Conclusions: This is the first case report of transient secondary anemia associated with thyrotoxicosis due to painless thyroiditis. The change in sIL-2R was also observed during the clinical course of thyrotoxicosis and anemia, suggesting the immune processes in thyroid gland and bone marrow.

Abstract Image

Abstract Image

无痛性甲状腺炎伴甲亢性贫血1例。
背景:有几篇与Graves病相关的继发性贫血的报道。无痛性甲状腺炎(无症状性甲状腺炎)导致甲状腺毒症继发贫血的报道尚未见。我们报告一例胰岛糖尿病患者,由于无痛性甲状腺炎导致甲状腺毒症导致贫血。病例介绍:患者为37岁男性,因疲劳、心悸和呼吸困难来医院就诊。血红蛋白110 g/l(参考范围135-176),平均红细胞体积81.5 fl(81.7-101.6)。游离甲状腺素(FT4)高,为100.4 pmol/l (11.6-21.9);游离三碘甲状腺原氨酸(FT3)较高,为27.49 pmol/l (3.53 ~ 6.14);TSH较低,为9 /l(30-100)。血清铁(Fe) 9.5(9.1 ~ 35.5),铁蛋白389 μg/l(13 ~ 401),触珠蛋白0.66 g/l(0.19 ~ 1.70)。开了心得安并进行了随访。发病12周后贫血完全消失。甲状腺激素和sIL-2R在发病后16周恢复正常。患者出现轻度甲状腺功能减退,24周时给予l -甲状腺素治疗。结论:这是首例无痛性甲状腺炎引起的短暂性继发性贫血合并甲状腺毒症的病例报道。在甲状腺毒症和贫血的临床过程中也观察到sIL-2R的变化,提示甲状腺和骨髓的免疫过程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Thyroid Research
Thyroid Research Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
3.10
自引率
4.50%
发文量
21
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信